Categories AlphaGraphs, Earnings, LATEST, Technology

Infosys Q3 revenue beats estimates; earnings miss

Infosys (INFY) reported better-than-expected revenues for the third quarter of 2019 while earnings came in shy of estimates. The stock was up 2.9% in premarket hours on Friday.

Total revenues grew 8.4% to $2.98 billion from the year-ago quarter. On a constant currency basis, revenues grew 10.1%. Net profit dropped to $502 million or $0.12 per share from $796 million or $0.17 per share in the prior-year period.

Infosys third quarter 2019 earnings infographic
Infosys Q3 2019 Earnings Infographic

During the quarter, Infosys recorded revenue increases in both its digital and core businesses, with digital revenues growing 33.1% year-on-year to $942 million in constant currency terms. Revenues remained relatively flat across most business segments and geographies on a year-over-year basis. The company secured $1.57 billion in large deal signings during the quarter.

Infosys revised its revenue guidance for fiscal year 2019 to 8.5% to 9% on a constant currency basis. Operating margin guidance was retained at 22% to 24%.

Infosys had previously classified its subsidiaries Kallidus & Skava and Panaya as Held for Sale. During the third quarter, based on evaluation of proposals and negotiations with buyers, the company concluded that the chances of completing a sale by March 31, 2019 were very low.

Accordingly, both assets have been de-classified from Held for Sale and the company incurred additional depreciation and amortization expenses of $12 million in the process. The company also recognized a reduction of $65 million in the carrying value of Skava. Infosys plans to repurpose Skava’s micro services-based business and refocus Panay’s product suite.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal

Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities

Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close